brentuximab vedotin
seagen,takeda
['lymphoma', 'hodgkin', 'lymsm', 'cml']
#17icml p borchmann reviews the evolution of #hodgkin #lymphoma treatment in the last decades and how we have improved not only outcome but also reduced toxicity #lymsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member